22 completed, 1 terminated, 1 withdrawn. 24 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 24 | Completed 22, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Renal Transplantation: new trials by email Literature Review of Renal Transplantation trials Research Report on Renal Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation Corticosteroid boluses Methylprednisolone, No therapeutic modification, Stop maintenance corticotherapy - Renal Transplantation | Phase 3 | Completed | Hospices Civils de Lyon | 346 | 2015-09-02 | 2025-10-01 |
| Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation voclosporin, tacrolimus - Renal Transplantation | Phase 3 | Withdrawn | Aurinia Pharmaceuticals Inc. | 2013-03-01 | 2014-01-20 | |
| 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients Everolimus, Tacrolimus, Cyclosporin A - Kidney Transplantation, Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 612 | 2012-12-27 | 2017-05-01 |
| Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids. everolimus, cyclosporine, Prednison (continuous steroids) - de Novo Kidney Transplant Recipients, Renal Transplantation | Phase 3 | Completed | Novartis | 330 | 2009-04-01 | 2016-07-19 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients Enteric-coated mycophenolate sodium (EC-MPS), Prednisone - Renal Transplantation | Phase 3 | Completed | Novartis | 222 | 2007-04-01 | 2011-04-21 |
| The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates simvastatin - Renal Transplantation | Phase 2 / Phase 3 | Completed | Shiraz University of Medical Sciences | 82 | 2007-04-01 | 2008-06-09 |
| Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance. Everolimus + Cyclosporine, Everolimus + Enteric-coated Mycophenolate Sodium (EC-MPS), Steroids - Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 30 | 2006-10-01 | 2017-03-30 |
| Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN) Sevoflurane, Propofol - End-stage Chronic Renal Disease, Severe Acute Kidney Failure | Phase 3 | Completed | University Hospital, Bordeaux | 120 | 2006-06-01 | 2026-05-14 |
| Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients Enteric-coated mycophenolate sodium (EC-MPS) - Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 128 | 2006-06-01 | 2011-03-29 |
| Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients FTY720 - Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 140 | 2005-05-01 | 2011-11-02 |
| Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant Cyclosporin A, Belatacept Less Intensive Regimen (LI), Belatacept More Intensive Regimen (MI) - Renal Transplantation | Phase 3 | Completed | Bristol-Myers Squibb | 595 | 2005-02-01 | 2017-07-07 |
| Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients Cyclosporine, Daclizumab, Mycophenoate Mofetil - Renal Transplantation | Phase 3 | Completed | Hoffmann-La Roche | 237 | 2004-11-01 | 2016-02-19 |
| Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients FTY720 - Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 684 | 2004-05-01 | 2017-02-23 |
| Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients FTY720 - Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 684 | 2004-04-01 | 2011-11-02 |
| Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients Everolimus - Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 80 | 2003-11-01 | 2011-11-02 |
| Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients Enteric-Coated Mycophenolate Sodium (EC-MPS) - Renal Transplantation | Phase 3 | Completed | Novartis | 69 | 2003-04-01 | 2011-01-31 |
| Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients FTY720 - Renal Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 684 | 2003-04-01 | 2017-08-22 |
| Cranoc Lipid Study in Renal Transplantation Fluvastatin - Renal Transplantation | Phase 2 / Phase 3 | Terminated | University Hospital Schleswig-Holstein | 200 | 2003-04-01 | 2011-08-08 |
| Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants Enteric-Coated Mycophenolate Sodium (EC-MPS) - Renal Transplantation | Phase 3 | Completed | Novartis | 55 | 2003-02-01 | 2011-01-31 |
| Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients Sirolimus, tacrolimus, Cyclosporine A - Renal Transplantation | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 830 | 2002-01-01 | 2010-05-14 |
Showing 20 of 24. Sign in to see all of them.
Acute Kidney Injury (1) · Graft vs Host Disease (1) · Ischemia (1) · Kidney Failure, Chronic (1) · Rejection, Psychology (1) · Renal Insufficiency (1)
Behavior (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency, Chronic (1) · Social Behavior (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Cyclosporine (7) · Everolimus (6) · Mycophenolic Acid (5) · Fingolimod Hydrochloride (4) · Sirolimus (3) · Tacrolimus (3) · Daclizumab (2) · Adrenal Cortex Hormones (1) · Basiliximab (1) · Fluvastatin (1) · Prednisolone (1) · Prednisone (1) · Propofol (1) · Sevoflurane (1) · Simvastatin (1)
Novartis Pharmaceuticals (10) · Novartis (4) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Aurinia Pharmaceuticals Inc. (1) · Bristol-Myers Squibb (1) · Hoffmann-La Roche (1) · Hospices Civils de Lyon (1) · Shiraz University of Medical Sciences (1) · University Hospital Schleswig-Holstein (1) · University Hospital, Bordeaux (1) · University Hospital, Lille (1)
France (8) · Germany (4) · Italy (2) · Switzerland (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Czechia (1) · Hungary (1) · Iran (1) · Norway (1)
Daniel Abramowicz, MD, PhD (1) · Lutz Renders, MD (1)
PMID 15949912, PMID 17565578, PMID 18360262, PMID 22143911, PMID 22300431, PMID 24831918, PMID 26888217, PMID 38993854
2014 (1)